Last Friday, pharma giant AstraZeneca announced that it had received the go-ahead from the Drug Controller General of India (DCGI) to import and market durvalumab (ImfinziTM) in India. The receipt of this permission paves the way for the launch of durvalumab (ImfinziTM) in India. Durvalumab which is a patented drug of Astra-Zeneca, received permission in India to provide treatment for patients with unresectable non-small cell lung cancer and metastatic urothelial carcinoma.
Key findings of the FHI 2018 allude to the lack of access on account of low skilled physician density and a low number of hospital beds. The study also highlighted the fact that semi-urban and rural areas are yet to leverage the advancements of digital healthcare. It also stated that healthcare professionals in the country were open to the deployment of futuristic technology such as AI and virtual reality in healthcare as compared to the general population.
The IPO has provided the biotech major with the financial bandwidth to aggressively pursue its new generation of CAR-T variants on a broader level, with the advancement of several therapies or the start of clinical trials over the next couple of months.
The new business with unique data-driven capabilities will work as a private healthcare IT company with a big impact in the health sector by reducing waste and improving quality outcomes and affordability as well as offering opportunities to create substantial value for clients.
Hypothyroidism is a condition where the thyroid gland is underactive meaning that it does not produce a sufficient amount of thyroid hormones. A common cause of hypothyroidism is Hashimoto’s thyroiditis, an autoimmune disease where the body produces antibodies which attack the thyroid.
With the aid of scholarship-funded programs and start-up accelerators, many health start-ups have progressed and attained profitability. Now there is good news for small start-ups who seek funding to solve ongoing global medical issues. RebelBio’s start-up acceleration program offers up to £200K twice every year for life sciences start-ups to carry out scientific works.
AutoDietary has got a microphone on the back to record the food chewing sound. This information will be sent to a connected smartphone via Bluetooth. The sound will then be uploaded to the cloud database, where it would be compared with existing chewing data for varied foods.
Blockchain technologies have devised a method to obtain a patient’s health records from a blockchain database even if they are unable to communicate. A verification from two different keys is needed for this step.
When the FDA approved this drug, there was an additional demand from the FDA to conduct post-marketing studies and assess the drug’s safety. Recently, a non-profit consumer advocacy group sent a petition requesting that the FDA should eliminate the drug from the U.S. pharma market since the drug shows significant risk of cardiovascular diseases.
Administration of two doses of BCG with a duration of four weeks apart can normalize the blood sugar levels for up to eight years. Tumor necrosis factor (TNF) is a protein that eliminates improper immune cells that destroy pancreatic islets, involved in immune production. But the administration of BCG can ultimately regulate T cells and boost TNF production.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.